George Okafo (GSK's In-silico drug discovery unit)

Adapting drug discovery to Artificial Intelligence

25 July 2018 | By Ami S Lakdawala (GSK's In-silico drug discovery unit), George Okafo (GSK's In-silico drug discovery unit), John Baldoni (GSK's In-silico drug discovery unit), Michael Palovich (GSK's In-silico drug discovery unit), Tobias Sikosek (GSK's In-silico drug discovery unit), Vishal Sahni (GSK's In-silico drug discovery unit)

Drug discovery has always been challenging; today, more so than ever. While there has been success in addressing many diseases, others remain intractable...